top
Please input keywords
OK
Database
ニュース&PR
お問い合わせ
JP
CN
EN
KR
About us
会社情報
私たちの歩み
管理スタッフ
企業文化
社会的責任
共に働く
Antibody Assets
Project Integrum
Antibody discovery platforms
Pipeline
Clinical pipeline
Preclinical pipeline
RenMice
RenMab
RenLite
RenNano
動物・細胞モデル
Pharmacology service
ゲノム編集
研究提携
IR
Stock Information
Financial Reports
Listing Documents
Announcements & Notices
Corporate Governance
Investor Calendar
Email Alert
IR Contact
Home
News events
ウェビナー
Text
Antibody Screening Strategy using Humanized Efficacy Mouse Models and Fully Human Therapeutic Antibody Development Based on RenMab Mouse
2021.05.07
Antibody Screening Strategy using Humanized Efficacy Mouse Models and Fully Human Therapeutic Antibody Development Based on RenMab Mouse
Prev:In vivo efficacy and safety ev...
Next:Design and Screening of Bispec...